Medplus Health Services shares added 3% in early trade on February 26 even after the company's subsidiary received a suspension order from Drugs and Control Authorities of Mahabubnagar, Telangana. At 9:37am Medplus Health Services was quoting Rs 710.10, up Rs 20.90, or 3.03 percent, on the BSE. The company received the order on February 23 and estimated a potential revenue loss of Rs 1.63 lakh.